← Back to MXCT

MaxCyte, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$4.9$4.5$4.6$5.8$5.7$5.6$5$5.6
−$8.9−$4.8−$12−$12−$10−$12−$9.4−$9.5
−$0.08−$0.04−$0.12−$0.12−$0.10−$0.11−$0.09−$0.09
107107107106106105105104

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.